Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning

por Kesler, Shelli R., Rao, Arvind, Blayney, Douglas W., Oakley-Girvan, Ingrid A., Karuturi, Meghan, Palesh, Oxana
Publicado 2017

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

por Smith‐Graziani, Demetria, Lei, Xiudong, Giordano, Sharon H., Zhao, Hui, Karuturi, Meghan, Chavez‐MacGregor, Mariana
Publicado 2020

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer

por Layman, Rachel M., Lin, Heather, Gutierrez Barrera, Angelica M., Karuturi, Meghan S., Yam, Clinton, Arun, Banu K.
Publicado 2022

Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

por Ring, Alistair, Karuturi, Meghan, Smyth, Emily Nash, Lokhandwala, Tasneem, Sheffield, Kristin M., Willey, Joanne, Lunacsek, Orsolya, Sapunar, Francisco, Cui, Zhanglin Lin, Coutinho, Anna, Rybowski, Sarah
Publicado 2023

Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions:...

por Gelmon, Karen, Walshe, Janice M., Mahtani, Reshma, Joy, Anil A., Karuturi, Meghan, Neven, Patrick, Lu, Dongrui Ray, Kim, Sindy, Schnell, Patrick, Bananis, Eustratios, Schwartzberg, Lee
Publicado 2021

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer

por Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G., Wang, Yamei, Conlan, Maureen G., Kabos, Peter
Publicado 2021

Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation

por Bashour, Sami I., Doostan, Iman, Keyomarsi, Khandan, Valero, Vicente, Ueno, Naoto T., Brown, Powel H., Litton, Jennifer K., Koenig, Kimberly B., Karuturi, Meghan, Abouharb, Sausan, Tripathy, Debasish, Moulder-Thompson, Stacy L., Ibrahim, Nuhad K.
Publicado 2017

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

por Vijayaraghavan, Smruthi, Karakas, Cansu, Doostan, Iman, Chen, Xian, Bui, Tuyen, Yi, Min, Raghavendra, Akshara S., Zhao, Yang, Bashour, Sami I., Ibrahim, Nuhad K., Karuturi, Meghan, Wang, Jing, Winkler, Jeffrey D., Amaravadi, Ravi K., Hunt, Kelly K., Tripathy, Debu, Keyomarsi, Khandan
Publicado 2017

Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16(INK4a)

por Shachar, Shlomit S, Deal, Allison M, Reeder-Hayes, Katherine E, Nyrop, Kirsten A, Mitin, Natalia, Anders, Carey K, Carey, Lisa A, Dees, E Claire, Jolly, Trevor A, Kimmick, Gretchen G, Karuturi, Meghan S, Reinbolt, Raquel E, Speca, JoEllen C, Muss, Hyman B
Publicado 2020

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

por Mitin, Natalia, Nyrop, Kirsten A., Strum, Susan L., Knecht, Anne, Carey, Lisa A., Reeder-Hayes, Katherine E., Claire Dees, E., Jolly, Trevor A., Kimmick, Gretchen G., Karuturi, Meghan S., Reinbolt, Raquel E., Speca, JoEllen C., O’Hare, Erin A., Muss, Hyman B.
Publicado 2022

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

por Haddad, Tufia C., Suman, Vera J., D’Assoro, Antonino B., Carter, Jodi M., Giridhar, Karthik V., McMenomy, Brendan P., Santo, Katelyn, Mayer, Erica L., Karuturi, Meghan S., Morikawa, Aki, Marcom, P. Kelly, Isaacs, Claudine J., Oh, Sun Young, Clark, Amy S., Mayer, Ingrid A., Keyomarsi, Khandan, Hobday, Timothy J., Peethambaram, Prema P., O’Sullivan, Ciara C., Leon-Ferre, Roberto A., Liu, Minetta C., Ingle, James N., Goetz, Matthew P.
Publicado 2023

Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

por Kalra, Maitri, Henry, Elizabeth, McCann, Kelly, Karuturi, Meghan S, Bustamante Alvarez, Jean G, Parkes, Amanda, Wesolowski, Robert, Wei, Mei, Mougalian, Sarah S, Durm, Gregory, Qin, Angel, Schonewolf, Caitlin, Trivedi, Meghna, Armaghani, Avan J, Wilson, Frederick H, Iams, Wade T, Turk, Anita A, Vikas, Praveen, Cecchini, Michael, Lubner, Sam, Pathak, Priyadarshini, Spencer, Kristen, Koshkin, Vadim S, Labriola, Matthew K, Marshall, Catherine H, Beckermann, Katy E, Sharifi, Marina N, Bejjani, Anthony C, Hotchandani, Varsha, Housri, Samir, Housri, Nadine
Publicado 2022